Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 重庆智飞生物制品股份有限公司是一家从事疫苗、生物制品的研发、生产和销售的公司.全资子公司绿竹制药主要从事以预防脑膜炎、肺炎为主的细菌性疫苗产品的研发、生产和销售;全资子公司安徽龙科马主要从事防治结核病类生物制品及病毒类疫苗的研发、生产和销售;全资子公司重庆智仁主要从事疫苗产品的销售.公司是我国本土综合实力最强的民营生物疫苗企业之一.截至2010年,最近三年公司疫苗产品销售量在民营疫苗企业中排名第一.公司也是国内少数几家具有丰富自主疫苗产品系列的厂家之一。 | ||||||||||||||||||||||||
Main Business | 疫苗、生物制品的研发、生产和销售。 | ||||||||||||||||||||||||
Legal Representative | 蒋仁生 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 秦菲 | ||||||||||||||||||||||||
Solicitors | 北京市金杜律师事务所 | ||||||||||||||||||||||||
Auditors | 中瑞岳华会计师事务所有限公司 | ||||||||||||||||||||||||
Tel No | 023-86358226 | ||||||||||||||||||||||||
Fax No | 023-86358685 | ||||||||||||||||||||||||
Website | www.zhifeishengwu.com | ||||||||||||||||||||||||
IRM@zhifeishengwu.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 28/09/2010 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 3.362 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.800 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 13.128 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 39.827B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |